fortune gems 3 apk latest version

fortune gems 3 apk latest version Vederian Lowe was fined for unnecessary roughness during the New England Patriots ’ Week 12 game against the Miami Dolphins. The NFL fined the starting left tackle $5,472 for a blindside block during the fourth quarter of New England’s loss at Hard Rock Stadium. The play happened with 10:10 left in the game on a 2-point conversion. There was no play on the call and New England successfully converted. While no penalty was called on the play, Lowe has had penalty issues throughout the season. He’s one of the NFL’s most penalized players and has only played in nine games. Lowe was charged with three false starts and a hold against the Dolphins last week and also gave up a strip sack. The pre-snap penalties hurt the Patriots last week in the blowout loss and Lowe took accountability and didn’t place blame on the officials or coaches. “The pre-snap penalties hurt the most because that’s nothing that nobody else is doing. ... It’s just not being mentally focused enough,” Lowe said. “You know, it’s an easy fix. Like I said, it’s not nothing that the defense is doing. It’s not nothing that the coaches, it’s not a scheme thing, it’s not the refs. It’s nobody else but yourself. So I would say it’s definitely lack of focus.” Lowe is questionable for Sunday’s game against the Indianapolis Colts with a shoulder injury. More Patriots ContentSanta, maybe? Why we have different names for who ‘hurries down the chimney’ on Christmas

NEW YORK (AP) — U.S. stock indexes fell Thursday following some potentially discouraging data on the economy . The S&P 500 slipped 0.5% for its fourth loss in the last six days. It’s a pause for the index, which has been rallying toward one of its best years of the millennium . The Dow Jones Industrial Average lost 234 points, or 0.5%, and the Nasdaq composite sank 0.7% from its record set the day before. A report early in the morning said more U.S. workers applied for unemployment benefits last week than expected. A separate update, meanwhile, showed that inflation at the wholesale level, before it reaches U.S. consumers, was hotter last month than economists expected. Neither report points to imminent disaster, but they dilute one of the hopes that’s driven the S&P 500 to 57 all-time highs so far this year : Inflation is slowing enough to convince the Federal Reserve to keep cutting interest rates, while the economy is remaining solid enough to stay out of a recession. Of the two reports, the weaker update on the job market may be the bigger deal for the market, according to Chris Larkin, managing director, trading and investing, at E-Trade from Morgan Stanley. A surge in egg prices may have been behind the worse-than-expected inflation numbers. “One week doesn’t negate what has been a relatively steady stream of solid labor market data, but the Fed is primed to be sensitive to any signs of a softening jobs picture,” he said. Traders are widely expecting the Fed will ease its main interest rate at its meeting next week. If they’re correct, it would be a third straight cut by the Fed after it began lowering rates in September from a two-decade high. It’s hoping to support a slowing job market after getting inflation nearly all the way down to its 2% target. Lower rates would give a boost to the economy and to prices for investments, but they could also provide more fuel for inflation. A cut next week would have the Fed following other central banks, which lowered rates on Thursday. The European Central Bank cut rates by a quarter of a percentage point, as many investors expected, and the Swiss National Bank cut its policy rate by a steeper half of a percentage point. Following its decision, Switzerland’s central bank pointed to uncertainty about how U.S. President-elect Donald Trump’s victory will affect economic policies, as well as about where politics in Europe is heading. Trump has talked up tariffs and other policies that could upend global trade. He rang the bell marking the start of trading at the New York Stock Exchange on Thursday to chants of “USA.” On Wall Street, Adobe fell 13.7% and was one of the heaviest weights on the market despite reporting stronger profit for the latest quarter than analysts expected. The company gave forecasts for profit and revenue in its upcoming fiscal year that fell a bit shy of analysts’. Warner Bros. Discovery soared 15.4% after unveiling a new corporate structure that separates its streaming business and film studios from its traditional television business. CEO David Zaslav said the move “enhances our flexibility with potential future strategic opportunities,” raising speculation about a spinoff or sale. Kroger rose 3.2% after saying it would get back to buying back its own stock now that its attempt to merge with Albertsons is off . Kroger’s board approved a program to repurchase up to $7.5 billion of its stock, replacing an existing $1 billion authorization. All told, the S&P 500 fell 32.94 points to 6,051.25. The Dow Jones Industrial Average dropped 234.55 to 43,914.12, and the Nasdaq composite sank 132.05 to 19,902.84. In stock markets abroad, European indexes held relatively steady following the European Central Bank’s cut to rates. Asian markets were stronger. Indexes rose 1.2% in Hong Kong and 0.8% in Shanghai as leaders met in Beijing to set economic plans and targets for the coming year. South Korea’s Kospi rose 1.6% for its third straight gain of at least 1%, as it pulls back following last week’s political turmoil where its president briefly declared martial law. In the bond market, the 10-year U.S. Treasury yield rose to 4.33% from 4.27% late Wednesday. AP Business Writers Matt Ott and Elaine Kurtenbach contributed.

Buckingham Palace maid ARRESTED for assault after staff Xmas party descends into boozy brawl in All Bar One

During the Callaway Future Champions Golf Hawaii World Series Championship tournament, St. John’s School’s Aki Matsuno finished tied for second place. In the two-round tournament, which was held Nov. 23-24 and played at the Kapolei Golf Club in Kapolei, Hawaii, Matsuno shot an opening round 79 but, in the second round, followed the above-par performance with a tournament-best 69. “We are pleased to announce that (Guam National Golf Federation) national team player Aki Matsuno has secured second place at the recently concluded FCG Hawaii World Series Championship,” the federation said in a press release. “Aki’s second-place finish earned him an invitation to compete in the upcoming FCG Junior Golf Championship to be held in July 2025.”THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgen

TORONTO (AP) — Canada’s most populous province may bar American-made alcohol in addition to restricting electricity exports to Michigan, New York and Minnesota if U.S. President-elect Donald Trump imposes sweeping tariffs on all Canadian products, a senior official said Thursday. The official in Ontario Premier Doug Ford’s government said that it’s contemplating restricting Ontario’s liquor control board from buying American-made alcohol. Ontario is also considering restricting exports of critical minerals required for electric vehicle batteries and preventing U.S.-based companies from the government’s procurement process, the official said on condition on anonymity because the functionary wasn’t authorized to speak publicly about the potential measures. Ford confirmed on Wednesday evening that Ontario is contemplating restricting electricity exports to Michigan, New York State and Minnesota. He reiterated that on Thursday and said it would make electricity unaffordable for Americans. “It’s a last resort,” Ford said. “I don’t think President-elect Trump wants that to happen. We’re sending a message to the U.S. If you come and attack Ontario, you attack livelihoods of people in Ontario and Canadians, we are going to use every tool in our tool box to defend Ontarians and Canadians. Let’s hope it never comes to that.” Trump has threatened to impose a 25% tax on all products entering the United States from Canada and Mexico unless they stem the flow of migrants and drugs . Ontario powered 1.5 million homes in the U.S. in 2023 and is a major exporter of electricity to Michigan, Minnesota and New York. “That’s OK if he that does that. That’s fine,” Trump told CNBC when asked about Ford’s remarks on the floor of the New York Stock Exchange. “The United States is subsidizing Canada and we shouldn’t have to do that,” Trump said. “And we have a great relationship. I have so many friends in Canada, but we shouldn’t have to subsidize a country. We’re subsidizing more than a $100 billion a year. We shouldn’t have to be doing that.” The CNBC reporter said off camera that Trump told him that they hope they can work something out with Canada. The premier of the oil rich Canadian province of Alberta ruled out cutting off oil exports. “Under no circumstances will Alberta agree to cut off oil and gas exports,” Alberta Premier Danielle Smith said. “Instead, we’re taking a diplomatic approach and we’re meeting with our allies in the U.S. We’re making the case for Alberta oil and gas to be part of the solution to energy affordability and energy security.” Canada supplies more oil to the U.S. than any other country, nearly 4.5 million barrels a day. About 60% of U.S. crude oil imports are from Canada and a fifth of the crude refined in the U.S. comes from Canada. “If you put a 25% tariff on oil from Alberta that increases every gallon of gasoline by one dollar,” Ford said. About 85% of U.S. electricity imports come from Canada as well. Canada also has 34 critical minerals and metals the Pentagon is eager for. Nearly 3.6 billion Canadian dollars ($2.7 billion) worth of goods and services cross the border each day. Canada is the top export destination for 36 U.S. states. Canada has promised more border security spending to address Trump’s border concerns. Ford said that will include more border and police officers, as well as drones and sniffer dogs. Public Safety Minister Dominic LeBlanc, who along with Prime Minister Justin Trudeau recently had dinner with Trump at Mar-a-Lago, his private club in Florida, said they plan to share details of those border plans with the incoming Trump administration in the coming days. Alberta’s government is creating a new sheriff patrol unit to shore up security at the border. It will be supported by about 50 sheriffs, 10 cold weather surveillance drones and four drug detection dogs. Alberta Public Safety Minister Mike Ellis said a two-kilometer (1.2-mile) deep zone along the border with Montana will be deemed critical infrastructure, so sheriffs can arrest without a warrant anyone found attempting to cross illegally or trafficking illegal drugs or weapons. At the Mar-a-Lago dinner, Kristen Hillman, Canada’s ambassador to the U.S., said that Washington’s trade deficit with Canada was also raised. Hillman said the U.S. had a $75 billion trade deficit with Canada last year but noted a third of what Canada sells into the U.S. is energy exports and prices have been high. Trudeau said this week that U.S.-imposed tariffs would be “absolutely devastating” for the Canadian economy , but it would also mean real hardship for Americans. Canada imposed duties in 2018 against the U.S. in a tit-for-tat response to new taxes on Canadian steel and aluminum. Canadian officials have said that it’s unfair to lump Canada in with Mexico. LeBlanc said that illegal migration from Canada to the U.S. is only 0.6% of the total, and fentanyl from Canada is 0.2% of the total of U.S. seizures. Quebec Premier Françoise Legault said that Trump told him in Paris last week that he doesn’t want to see anymore illegal immigration coming from Canada. Quebec is a major supplier of electricity to the U.S. Legault noted Trudeau’s plan to strengthen border security. “I prefer that than starting a war and stopping sending energy to the United States,” Legault said. Newfoundland Premier Andrew Furey said he had a call with New England governors this week and said there is a significant degree of concern on both sides of the border. “We hope it is just bluster,” Furey said. “We are preparing as if it is not. There will be no winner in a trade war.”Zelensky demands response from allies as Putin threatens West with new missile

Fans of Golden Bachelor are feeling bad about continuously slamming leading man Gerry Turner after he recently announced he has Waldenstrom’s macroglobulinemia, a slow-growing bone marrow cancer that has no cure. The former reality TV star has received a tremendous amount of hate throughout his time as the first-ever Golden Bachelor. After the Hollywood Reporter claimed Gerry lied about his personal and romantic life, fans turned on him and the hate only escalated once he and wife Theresa Nist announced their divorce after only three months of marriage. Golden Bachelor's Gerry Turner was diagnosed with cancer weeks before split Golden Bachelorette's Joan and Chock address 'issues' in their relationship Since the divorce, Gerry has been criticized and slammed him for what they call his continued cringiness while sources have painted him black for claiming he agreed to be the lead of the show in hopes of a major reward . Even simply things like celebrating turning 73 , traveling by himself, doing charity work , and going on Golden Bachelorette to give leading lady Joan Vassos advice has earned him hateful comments from fans. Sign up to The Bachelor newsletter HERE for the latest news and updates Viewers who disliked Gerry through all of this called him cringey, a fraud, and selfish. However, some have now taken to a Reddit board called: "Gerry was diagnosed with Bone Marrow Cancer shortly before splitting with Teresa" to apologize to Gerry for constantly slamming him online. One person wrote in the comments: "Gerry, I was so rude to you under the cloak of the internet, and judged you prematurely with the regards to this breakup. I am so sorry." Another added: "gosh. this gave me a pit in my stomach. friendly reminder us internet folk dont know all thats happening behind the screens. its the holiday season guys, can we be kinder to these people now?" A third pointed out: "God, this makes me sad. He took all the bad comments about him on the chin. I felt bad when people were relentlessly crucifying him months ago." A fourth said: "Yeah people really hate Gerry on this sub and I’ve never understood why, even before this new heartbreaking info." DON'T MISS: Golden Bachelorette Pascal branded 'obnoxious' as he admits he does nothing [LATEST] Golden Bachelorette fans fume over 'dangerous' groupdate-'orthopedic's dream' [UPDATE] Golden Bachelorette viewers fume 'Gerry has ruined everything' after encounter [INSIGHT] A fifth penned: "And everyone on here was destroying him," as a sixth added: "What a shame! The fanbase stays pathetic thinking they know any of these people and what they go through." Others added: "Damn. The internet was cruel to him too," "Well that’s a shame. All the speculation and opinions from everyone was so negative, and they didn’t have any idea what he was going through. Poor guy," and "Damn, so many people speculated on how shitty he was at the time of the divorce." Fans did not look forward to Gerry returning to the franchise during Joan's season of Golden Bachelorette. When they spotted him in an episode trailer, they instantly took to social media to fume about his return. One person said: "Please No Gerry," as another penned: "GERRY NO ONE WANTS YOU HERE GET AWAY FROM JOAN." A third fumed with tons of eye-roll emoijis: "Gerry comes back???? For REAL????" as a fourth vented: "I was actually hoping to never see Gerry again." A fifth simply added: "Nooo not Gerry." Gerry shocked fans by officially announcing he was diagnosed with cancer weeks before he and Theresa Nist split earlier this year. “I wanted my life to continue on as normal as possible, and that led me to believing that as normal as possible more meant spending time with my family, my two daughters, my two son-in-laws, my granddaughters,” he told People. “And the importance of finding the way with Theresa was still there, but it became less of a priority,” he added. He also said that he hoped the truth being out there would get those who criticized him and Theresa to change their tune. “I hope that people understand in retrospect now that that had a huge bearing on my decisions and I think probably Theresa’s as well,” he said. “Hopefully they’ll look at things a little bit differently, that maybe it wasn’t quite a rash, fast decision that people thought. That there was something else going on.” He also shared that he still thought fondly of Theresa, and that he wished they had a “different ending,” noting that things might have been different if he hadn’t received te diagnosis he did. Following Gerry’s reveal, Theresa released her own statement, indicating that she didn’t leave him because he was sick, and admitting that she was also very upset by the news.

Nearly half of American teenagers say they are online “constantly” despite concerns about the effects of social media and smartphones on their mental health, according to a new report published Thursday by the Pew Research Center. As in past years, YouTube was the single most popular platform teenagers used — 90% said they watched videos on the site, down slightly from 95% in 2022. Nearly three-quarters said they visit YouTube every day. There was a slight downward trend in several popular apps teens used. For instance, 63% of teens said they used TikTok, down from 67% and Snapchat slipped to 55% from 59%. This small decline could be due to pandemic-era restrictions easing up and kids having more time to see friends in person, but it's not enough to be truly meaningful . X saw the biggest decline among teenage users. Only 17% of teenagers said they use X, down from 23% in 2022, the year Elon Musk bought the platform. Reddit held steady at 14%. About 6% of teenagers said they use Threads, Meta's answer to X that launched in 2023. The report comes as countries around the world are grappling with how to handle the effects of social media on young people's well-being. Australia recently passed a law banning kids under 16 from social networks, though it's unclear how it will be able to enforce the age limit — and whether it will come with unintended consequences such as isolating vulnerable kids from their peers. Meta's messaging service WhatsApp was a rare exception in that it saw the number of teenage users increase, to 23% from 17% in 2022. Pew also asked kids how often they use various online platforms. Small but significant numbers said they are on them “almost constantly.” For YouTube, 15% reported constant use, for TikTok, 16% and for Snapchat, 13%. As in previous surveys, girls were more likely to use TikTok almost constantly while boys gravitated to YouTube. There was no meaningful gender difference in the use of Snapchat, Instagram and Facebook. Roughly a quarter of Black and Hispanic teens said they visit TikTok almost constantly, compared with just 8% of white teenagers. The report was based on a survey of 1,391 U.S. teens ages 13 to 17 conducted from Sept. 18 to Oct. 10, 2024.Watchdog finds FBI missteps before Jan. 6 riot, but no undercover agents were presentTesla ( TSLA 3.67% ) shares have been on a roll in recent weeks. The stock has soared by more than 60% in the last month and that surge continued Friday. Tesla shares were higher by 3.7% as of 1:45 p.m. ET. That brings year-to-date gains to about 42%. Much of the recent euphoria has been related to CEO Elon Musk and his relationship with President-elect Donald Trump. But the stock's momentum may have also gotten a boost after the latest European electric vehicle (EV) sales numbers were published yesterday. EV sales recovery European EV sales were up by about 7% year over year in October, according to the European Automobile Manufacturers' Association. That bodes well for Tesla for several reasons. First, that rise in fully electric car registrations compares to flat results overall for all power sources including hybrids and fossil fuel vehicles. And the October rise in battery electric vehicle registrations compares to a drop of 2.6% in 2024 through September. And Tesla specifically has been seeing expanding sales over the last two months. For all of Europe, including the U.K., Tesla sold over 58,000 EVs in September and October combined. That's a rise of 11.6% in just those two months versus 2023. Yet overall 2024 sales through October were still down nearly 12% for Tesla in Europe. Demand has sharply accelerated recently. That's a good sign as investors prepare to see what Tesla sales will look like globally in 2024. Europe is an important market for Tesla with its German manufacturing plant and increasing competition from both European and Asian EV makers. Investors would love to see Tesla showing sales are accelerating into the end of the year. Especially as Musk sits in a position to help steer the incoming administration's policies regarding electric vehicles. The rebound in Europe over the past two months is encouraging and is helping to keep Tesla's stock momentum going.